1. Home
  2. CMTL vs ACRV Comparison

CMTL vs ACRV Comparison

Compare CMTL & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMTL
  • ACRV
  • Stock Information
  • Founded
  • CMTL 1967
  • ACRV 2018
  • Country
  • CMTL United States
  • ACRV United States
  • Employees
  • CMTL N/A
  • ACRV 78
  • Industry
  • CMTL Radio And Television Broadcasting And Communications Equipment
  • ACRV Medicinal Chemicals and Botanical Products
  • Sector
  • CMTL Technology
  • ACRV Health Care
  • Exchange
  • CMTL Nasdaq
  • ACRV Nasdaq
  • Market Cap
  • CMTL 64.4M
  • ACRV 74.5M
  • IPO Year
  • CMTL N/A
  • ACRV 2022
  • Fundamental
  • Price
  • CMTL $3.03
  • ACRV $2.38
  • Analyst Decision
  • CMTL Strong Buy
  • ACRV Buy
  • Analyst Count
  • CMTL 1
  • ACRV 5
  • Target Price
  • CMTL $6.00
  • ACRV $14.67
  • AVG Volume (30 Days)
  • CMTL 297.2K
  • ACRV 1.3M
  • Earning Date
  • CMTL 11-10-2025
  • ACRV 11-13-2025
  • Dividend Yield
  • CMTL N/A
  • ACRV N/A
  • EPS Growth
  • CMTL N/A
  • ACRV N/A
  • EPS
  • CMTL N/A
  • ACRV N/A
  • Revenue
  • CMTL $499,528,000.00
  • ACRV N/A
  • Revenue This Year
  • CMTL N/A
  • ACRV N/A
  • Revenue Next Year
  • CMTL $5.15
  • ACRV $805.34
  • P/E Ratio
  • CMTL N/A
  • ACRV N/A
  • Revenue Growth
  • CMTL N/A
  • ACRV N/A
  • 52 Week Low
  • CMTL $1.19
  • ACRV $1.05
  • 52 Week High
  • CMTL $4.88
  • ACRV $8.00
  • Technical
  • Relative Strength Index (RSI)
  • CMTL 50.88
  • ACRV 58.82
  • Support Level
  • CMTL $2.72
  • ACRV $2.22
  • Resistance Level
  • CMTL $3.50
  • ACRV $2.39
  • Average True Range (ATR)
  • CMTL 0.25
  • ACRV 0.18
  • MACD
  • CMTL -0.02
  • ACRV 0.00
  • Stochastic Oscillator
  • CMTL 41.03
  • ACRV 79.17

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: